37 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among others. This Table of Contents 36 … review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals and policies agreed
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
, ethnic characteristics, age), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among … to permit substantive review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals
DEF 14A
udurd85d9255uu74
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.34
5xuptqtqbjo
21 Mar 22
Annual report
4:19pm
10-K
EX-10.40
psfhjc
21 Mar 22
Annual report
4:19pm
10-K
mfkyalj
21 Mar 22
Annual report
4:19pm
10-K
EX-10.31
yw9 eqin7rti4
21 Mar 22
Annual report
4:19pm
10-K
EX-10.38
l3ynsohaf4d3cmktmgc
21 Mar 22
Annual report
4:19pm
10-K
EX-10.36
9imusw ts2
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
v6dlo2 inzv430kjv
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
S-8
EX-99.1
mzrv q1g83
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.2
9uloz9384bxrxjdb8p
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.6
81964hi8 7flakc
26 Jul 21
Registration of securities for employees
4:15pm
424B4
kaz iqpvhy6goxq1n
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
kyfvtr90ukd
19 Jul 21
IPO registration (amended)
6:09am